OmicScouts
OmicScouts GmbH is a world leader in mass spectrometry-based proteomics, supporting drug and biomarker discovery through innovative technologies and assays. The company provides system-wide proteome assays, supports collaborations with top pharmaceutical and biotech companies, and offers tailored solutions for drug and biomarker discovery, disease research, and agrochemical applications. OmicScouts is committed to scientific excellence, technological innovation, and providing high-quality proteomics services to accelerate research and development in life sciences.
Industries
Nr. of Employees
small (1-50)
Products
Protein Turnover Atlas (protein half-life dataset)
A licensed resource containing measured protein degradation and re-synthesis rates for over 14,000 human proteins across 30+ cell lines and cell types to inform PK/PD modelling and modality development.
Reactive cysteine index (indexed chemoproteomics dataset)
Proprietary indexed dataset of reactive cysteine sites collected from cell- and lysate-based chemoproteomic experiments covering tens of thousands of cysteine sites across thousands of proteins, available as a reference for covalent-ligand projects.
Oligonucleotide-probe enrichment assay for DNA/RNA-binding proteins
Enrichment and quantitative profiling assay to measure proteins that bind specific nucleotide sequences, enabling identification of transcription-factor complexes, their modulators, and functional inhibitors.
DecryptM framework and associated dose/time-resolved proteomics dataset
Framework and large-scale dataset for analyzing drug-induced changes in phosphorylation, acetylation and ubiquitination in a concentration- and time-resolved manner; includes interactive access via proteomics repositories.
CysScout
A quantitative mass-spectrometry based chemoproteomics platform that enables the comprehensive mapping of reactive cysteines in a given system.
DrugPhosphoProfiler
An innovative mass spectrometry-based high-throughput platform for systematically measuring the effects of pharmaceutical agents on phosphorylation-dependent cellular networks in a proteome-wide and drug concentration-resolved manner.
Protein Turnover Atlas (protein half-life dataset)
A licensed resource containing measured protein degradation and re-synthesis rates for over 14,000 human proteins across 30+ cell lines and cell types to inform PK/PD modelling and modality development.
Reactive cysteine index (indexed chemoproteomics dataset)
Proprietary indexed dataset of reactive cysteine sites collected from cell- and lysate-based chemoproteomic experiments covering tens of thousands of cysteine sites across thousands of proteins, available as a reference for covalent-ligand projects.
Oligonucleotide-probe enrichment assay for DNA/RNA-binding proteins
Enrichment and quantitative profiling assay to measure proteins that bind specific nucleotide sequences, enabling identification of transcription-factor complexes, their modulators, and functional inhibitors.
DecryptM framework and associated dose/time-resolved proteomics dataset
Framework and large-scale dataset for analyzing drug-induced changes in phosphorylation, acetylation and ubiquitination in a concentration- and time-resolved manner; includes interactive access via proteomics repositories.
CysScout
A quantitative mass-spectrometry based chemoproteomics platform that enables the comprehensive mapping of reactive cysteines in a given system.
DrugPhosphoProfiler
An innovative mass spectrometry-based high-throughput platform for systematically measuring the effects of pharmaceutical agents on phosphorylation-dependent cellular networks in a proteome-wide and drug concentration-resolved manner.
Services
Outsourced mass-spectrometry-based services to identify molecular targets, determine target engagement and selectivity, and support hit triage in drug discovery projects.
Development and execution of targeted MS assays for multiplexed, sensitive quantification of selected protein panels across large sample sets to support translational biomarker studies.
Large-scale chemoproteomic screening workflows for profiling compound libraries, fragment sets, or electrophile collections for reactive-site engagement and specificity.
Integrative bioinformatics services combining proteomics with genomics/transcriptomics and other data types using machine learning, network analysis and multivariate statistics.
Tailored experimental designs including proteogenomics, PTM method development, photoaffinity labeling for binding-site mapping, and protein–protein interaction studies.
Outsourced mass-spectrometry-based services to identify molecular targets, determine target engagement and selectivity, and support hit triage in drug discovery projects.
Development and execution of targeted MS assays for multiplexed, sensitive quantification of selected protein panels across large sample sets to support translational biomarker studies.
Large-scale chemoproteomic screening workflows for profiling compound libraries, fragment sets, or electrophile collections for reactive-site engagement and specificity.
Integrative bioinformatics services combining proteomics with genomics/transcriptomics and other data types using machine learning, network analysis and multivariate statistics.
Tailored experimental designs including proteogenomics, PTM method development, photoaffinity labeling for binding-site mapping, and protein–protein interaction studies.
Expertise Areas
- Mass spectrometry-based proteomics
- Chemical proteomics and target deconvolution
- Targeted proteomics and biomarker verification
- Proteogenomics and multi-omics integration
Key Technologies
- LC-MS/MS shotgun proteomics
- Affinity-selection and label-free chemoproteomics
- Cellular thermal shift assay (CETSA) by MS
- Targeted MS (Parallel Reaction Monitoring with isotope standards)
News & Updates
Participation in the annual meeting of the German Society for Proteome Research, April 2-5, 2017.
Momentum Biotechnologies acquired OmicScouts GmbH, expanding proteomics capabilities and geographic reach.
Participation in BioEurope 2022 in Leipzig, October 24-26, with representation by Andreas Köpke.
Participation in the Proteomic Forum 2019, March 24-28, 2019.
Momentum Biotechnologies announced the acquisition of OmicScouts GmbH, a leader in mass spectrometry-based proteomics.
Participation in BioEurope 2022 in Leipzig, October 24-26, 2022.
Participation in the annual meeting of the German Society for Proteome Research, April 2-5, 2017.
Momentum Biotechnologies acquired OmicScouts GmbH, expanding proteomics capabilities and geographic reach.
Participation in BioEurope 2022 in Leipzig, October 24-26, with representation by Andreas Köpke.
Participation in the Proteomic Forum 2019, March 24-28, 2019.
Momentum Biotechnologies announced the acquisition of OmicScouts GmbH, a leader in mass spectrometry-based proteomics.
Participation in BioEurope 2022 in Leipzig, October 24-26, 2022.